Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| glutamatergic neuron | 4 studies | 37% ± 11% | |
| oligodendrocyte | 4 studies | 20% ± 2% | |
| GABAergic neuron | 3 studies | 34% ± 2% | |
| interneuron | 3 studies | 34% ± 14% | |
| oligodendrocyte precursor cell | 3 studies | 16% ± 0% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| brain | 5 studies | 29% ± 8% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| brain | 100% | 369.11 | 2642 / 2642 | 100% | 3.67 | 703 / 705 |
| adrenal gland | 100% | 257.66 | 258 / 258 | 98% | 3.77 | 226 / 230 |
| ovary | 100% | 252.59 | 180 / 180 | 98% | 3.25 | 422 / 430 |
| thymus | 100% | 250.02 | 653 / 653 | 98% | 2.44 | 591 / 605 |
| prostate | 100% | 190.63 | 245 / 245 | 98% | 2.50 | 490 / 502 |
| breast | 100% | 211.22 | 459 / 459 | 95% | 2.40 | 1066 / 1118 |
| uterus | 100% | 218.16 | 170 / 170 | 93% | 2.66 | 426 / 459 |
| liver | 100% | 214.74 | 226 / 226 | 89% | 1.92 | 361 / 406 |
| lung | 99% | 157.11 | 572 / 578 | 88% | 1.80 | 1022 / 1155 |
| esophagus | 100% | 157.03 | 1445 / 1445 | 87% | 1.73 | 160 / 183 |
| intestine | 100% | 167.95 | 965 / 966 | 87% | 1.69 | 459 / 527 |
| stomach | 100% | 156.64 | 358 / 359 | 87% | 1.70 | 249 / 286 |
| bladder | 100% | 165.19 | 21 / 21 | 87% | 1.75 | 436 / 504 |
| pancreas | 100% | 180.31 | 328 / 328 | 83% | 1.42 | 147 / 178 |
| skin | 100% | 231.03 | 1806 / 1809 | 68% | 1.36 | 319 / 472 |
| kidney | 100% | 193.44 | 89 / 89 | 60% | 0.96 | 543 / 901 |
| spleen | 100% | 156.49 | 241 / 241 | 0% | 0 | 0 / 0 |
| adipose | 100% | 151.35 | 1200 / 1204 | 0% | 0 | 0 / 0 |
| muscle | 99% | 186.44 | 798 / 803 | 0% | 0 | 0 / 0 |
| blood vessel | 99% | 127.11 | 1321 / 1335 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 97% | 1.75 | 28 / 29 |
| heart | 94% | 124.05 | 809 / 861 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 81% | 2.48 | 65 / 80 |
| tonsil | 0% | 0 | 0 / 0 | 80% | 1.96 | 36 / 45 |
| peripheral blood | 67% | 86.00 | 626 / 929 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
| GO_0006412 | Biological process | translation |
| GO_0000049 | Molecular function | tRNA binding |
| GO_0043915 | Molecular function | L-seryl-tRNA(Sec) kinase activity |
| GO_0005524 | Molecular function | ATP binding |
| GO_0016301 | Molecular function | kinase activity |
| Gene name | PSTK |
| Protein name | Chromosome 10 open reading frame 89, isoform CRA_b (Phosphoseryl-tRNA kinase) L-seryl-tRNA(Sec) kinase (EC 2.7.1.164) (O-phosphoseryl-tRNA(Sec) kinase) |
| Synonyms | C10orf89 hCG_41432 |
| Description | FUNCTION: Specifically phosphorylates seryl-tRNA(Sec) to O-phosphoseryl-tRNA(Sec), an activated intermediate for selenocysteine biosynthesis. . |
| Accessions | ENST00000368887.7 [Q8IV42-1] H7BYY4 ENST00000406217.8 Q8IV42 ENST00000405485.2 [Q8IV42-1] |